Monotherapy with the anti-cd20 monoclonal antibody rituximab in a kidney transplant recipient with posttransplant lymphoproliferative disease

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation proceedings 2002-06, Vol.34 (4), p.1178-1181
Hauptverfasser:	Pham, P.-T.T, Wilkinson, A.H, Gritsch, H.A, Pham, P.C.T, Miller, J.M, Lassman, C.R, Danovitch, G.M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult African Americans Antibodies, Monoclonal - therapeutic use Antibodies, Monoclonal, Murine-Derived Antigens, CD - immunology Antigens, CD20 - immunology Biological and medical sciences California Hematologic and hematopoietic diseases Humans Immunosuppressive Agents - therapeutic use Kidney Transplantation - immunology Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Lymphoproliferative Disorders - drug therapy Male Medical sciences Postoperative Complications - drug therapy Rituximab Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the urinary system Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!